General Archive
-
News releases
Phosphate Therapeutics acquires novel phosphate binder (PT20) from the Medical Research Council and secures development funding from Inventages venture capital for compound’s phase 2 development
Phosphate Therapeutics has acquired the global rights to PT20, a novel Phase 2 ready phosphate binder for the treatment of…
-
News releases
New drug discovery collaboration with University of Bristol launched
Collaboration aims to develop orally available small molecule TrkA antagonists for treatment of chronic intractable pain.
-
News releases
New cancer therapeutic antibody project launched
MRC Technology’s Therapeutic Antibody Group and The University of Aberdeen will work together on a project to develop a therapeutic…
-
News releases
Aptuscan acquired by Avacta
Aptuscan, a spin out company based on research carried out by Paul Ko Ferrigno whilst working at the MRC Cancer…
-
News releases
MRC Technology to manage intellectual property for AICR
This is the first such agreement signed by MRC Technology, delivering on a new strategy to broaden its service to…
-
Articles & blogs
Crowd sourcing in drug discovery
MRCT’s Justin Bryans has contributed to a Nature Reviews Drug Discovery article on crowd sourcing in drug discovery. To read…
-
Articles & blogs
The art of turning ideas into products
In the FT article ‘The art of turning ideas into products’ MRC Technology CEO Dave Tapolczay is quoted, describing our…
-
Articles & blogs
New Director of Corporate Partnerships appointed
Mike Johnson has been appointed Director, Corporate Partnerships. Mike joins MRC Technology to act as the principal conduit for communication…
-
News releases
MRC scientists redefine how our immune system responds to viruses
Landmark research from the Medical Research Council (MRC) has discovered that antibodies can fight viruses from within infected cells. This…
-
News releases
Scientists ‘give botox a facelift’ to improve use for Parkinson’s
Researchers funded by the Medical Research Council (MRC) have developed a new method of joining and rebuilding molecules in the…
-
News releases
1st patient treated with BAN2401
BAN2401, the antibody by MRC Technology humanized for Swedish biopharmaceutical company BioArctic Neuroscience AB (Stockholm), has entered clinical trials to…
-
News releases
MRC People Exchange Programme
The MRC People Exchange Programme aims to stimulate collaborative research across industry and academia, develop skills and transfer knowledge. It…